Short answer
Cardinal Health (CAH) filed its fiscal 2025 10-K annual report with the SEC on Aug 12, 2025. It reported revenue of $222.6B (−1.9% year over year) and net income of $1.6B.
- Top risk flagged: Legal risk: Potential exposure from product liability and self-insurance accruals noted in loss contingencies, specifics not quantified but integral to financial estimates
FY2025 key financial metrics · XBRL
- Revenue
- $222.6B
- −1.9% YoY
- Net income
- $1.6B
- +83.2% YoY
- Operating margin
- 1.0%
- +0.5 pp YoY
- Gross margin
- 3.7%
- +0.4 pp YoY
- EPS (diluted)
- $6.45
- +87.0% YoY
- ROE
- -56.1%
- −29.6 pp YoY
- Operating cash flow
- $2.4B
- −36.3% YoY
Source: XBRL data from the Cardinal Health (CAH) FY2025 10-K on SEC EDGAR. USD.
Cardinal Health FY2025 10-K analysis
AI summary of each section, grounded in the filing text
Risk Factors
- Legal risk: Potential exposure from product liability and self-insurance accruals noted in loss contingencies, specifics not quantified but integral to financial estimates
- Geopolitical exposure: GMPD segment manufacturing facilities in 12 countries including Germany, Japan, Malaysia, Mexico, and Costa Rica, subject to international operational risks
- Operational vulnerability: Inventories increased to $16.8B in 2025 from $15.0B in 2024, indicating susceptibility to supply chain disruptions affecting working capital
- Competitive risk: Goodwill impairment testing required for Navista & ION and Cardinal Health at-Home Solutions reporting units shows sensitivity to revenue growth and market conditions
- Financial risk: Long-term obligations rose to $8.0B in 2025 from $4.7B in 2024, increasing leverage and interest expense to $215M, up from $51M prior year
Generated from the filing text; verify against the original. How to read a 10-K
Other Cardinal Health annual reports
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.